Oxytocin Dosage Chart & Schedule
Oxytocin is an endogenous nine-amino-acid neuropeptide produced in the hypothalamus and released from the posterior pituitary. The injectable form (Pitocin/Syntocinon) is FDA-approved for labor induction and postpartum use, while intranasal oxytocin is widely researched for social bonding, trust, and anxiety.
In behavioral research, oxytocin is used intranasally and dosed in international units - commonly around 24 IU (roughly 40 mcg) per session before a task. This is separate from the approved IV obstetric form, which is dosed in milliunits per minute under clinical supervision.
Figures describe how Oxytocin is reported in the research literature and research-community references — not a recommendation for human use. For laboratory research only.
Dosage protocols
Commonly referenced research tiers. Start conservative; every compound and study context differs.
- Frequency
- Single pre-task dose
- Weekly total
- Study-specific
- Cycle
- Single session or short daily course
Lower end of common behavioral-study doses.
- Frequency
- Single pre-task dose
- Weekly total
- Study-specific
- Cycle
- Single session or short daily course
The most commonly cited intranasal research dose.
- Frequency
- Single pre-task dose
- Weekly total
- Study-specific
- Cycle
- Single session or short daily course
Higher end of the behavioral-research range.
Two entirely separate contexts
- The approved obstetric form is IV, dosed in milliunits per minute under supervision.
- Behavioral research uses an intranasal spray dosed in IU (about 24 IU is common).
- The two are not interchangeable in route, dose units, or purpose.
Does intranasal reach the brain?
- Plasma half-life is only minutes, yet behavioral effects are studied over a longer window.
- Whether and how intranasal delivery reaches central targets remains an open research question.
Ready to run this protocol?
Dosing is only as good as the vial. Research-grade peptides are third-party tested with published COAs from our top-rated source — reconstitute with confidence and skip the guesswork on identity and purity.
Handling & storage
- Behavioral-research oxytocin is a nasal-spray solution - not reconstituted for subcutaneous injection.
- Doses are given as measured sprays per nostril, typically ~30-45 minutes before a task.
- Store the nasal solution refrigerated; the in-use window is short.
- The approved IV obstetric form (Pitocin) is a distinct clinical product dosed in milliunits/min.
Oxytocin dosing FAQ
How is oxytocin dosed in behavioral research?
As an intranasal spray measured in international units - most commonly about 24 IU (roughly 40 mcg) per session, given shortly before a task.
Why IU instead of mcg or units on a syringe?
Oxytocin is standardized by biological activity (IU). Behavioral studies use an intranasal spray, so there is no U-100 syringe conversion; ~24 IU is about 40 mcg.
Is the research intranasal dose the same as the hospital (Pitocin) dose?
No. The approved obstetric form is given intravenously in milliunits per minute under clinical supervision - a completely separate route, dose, and purpose from intranasal research use.
How often is intranasal oxytocin dosed in studies?
Often as a single dose ~30-45 minutes before a task, though some protocols use short daily courses. Schedules are study-specific rather than a standing regimen.
Sources
Categories: Sexual Health, Nootropic & Cognitive · Status: Approved (see notes). This page is educational and for laboratory research use only; it is not medical advice.